|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/30 | (2006.01) |
| (11) | Number of the document | 2734551 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12817661.7 |
| Date of filing the European patent application | 2012-07-23 | |
| (97) | Date of publication of the European application | 2014-05-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation | 2018-04-10 |
| (86) | Number | PCT/IL2012/050267 |
| Date | 2012-07-23 |
| (87) | Number | WO 2013/014668 |
| Date | 2013-01-31 |
| (30) | Number | Date | Country code |
| 201161511055 P | 2011-07-24 | US |
| (72) |
ROTEM-YEHUDAR, Rinat, IL
SCHICKLER, Michael, IL
|
| (73) |
Cure Tech Ltd.,
Hayarkon Street 42, 81227 Yavne,
IL
|
| (74) |
Gediminas PRANEVIČIUS,
Advokatų profesinė bendrija IP FORMA, Užupio g. 30, LT-01203 Vilnius,
LT
|
| (54) | Humanizuotų imunomoduliuojančių monokloninių antikūnų variantai |
| VARIANTS OF HUMANIZED IMMUNOMODULATORY MONOCLONAL ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2018-07-13 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-07-23 |